跳至主要内容
临床试验/NCT03640689
NCT03640689招募中不适用

DEep VEin Lesion OPtimisation (DEVELOP) Trial: A Randomised, Assessor-blinded Feasibility Study of Iliac Vein Intervention for Venous Leg Ulcers

National University of Ireland, Galway, Ireland2 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2019年7月15日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
60
试验地点
2
主要终点
Ulcer Healing - Proportion of ulcers healed

研究概览

简要总结

This is a prospective, single centre, randomised controlled, feasibility study recruiting patients with lower limb venous ulceration and Great Saphenous incompetence. Patients will be randomised to undergo either truncal ablation and compression therapy or truncal ablation, simultaneous iliac interrogation with intravascular ultrasound and stenting of significant (>50%) iliac vein lesions plus compression therapy. The primary endpoints will be ulcer healing and procedural safety. Secondary endpoints include time to healing, quality of life and clinical scores, ulcer recurrence rates and rates of post-thrombotic syndrome. Follow up will be over a five-year period. This feasibility study is designed to include 60 patients. Should it be practicable a total of 594 patients would be required to adequately power the study to definitively address ulcer-healing rates.

详细描述

The single main research question for this trial is as follows: in adult patients with venous ulceration and great saphenous vein incompetence; does iliac vein assessment with IVUS and stenting of significant occlusive disease in addition to superficial great saphenous venous ablation and compression compared to superficial venous ablation and compression alone offer improved ulcer healing rates at three months following treatment?

Primary Objective To determine whether superficial venous ablation plus early iliac vein interrogation plus endovascular stenting in the presence of significant occlusive disease results in improved venous ulcer healing compared to superficial venous ablation plus compression therapy alone.

Secondary Objectives

  1. To determine the relative performance of duplex ultrasound compared to IVUS for the prediction of NIVLs 3. To determine the rate of primary or recurrent ulceration up to five years following intervention 4. To assess patient quality of life in the short and medium term following each mode of intervention

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
Double (Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Consenting patients
  • •aged 18 and over
  • •ultrasound detected Great Saphenous Venous incompetence
  • •an associated primary or recurrent lower limb venous ulcer(s)

排除标准

  • •Ankle-brachial pressure index <0.8
  • •Previous inability to tolerate lower limb compression bandaging
  • •Inability to provide informed consent
  • •Previous lower limb arterial revascularisation procedure
  • •Contrast allergy
  • •Previous history of pelvic malignancy or pelvic radiotherapy
  • •Pregnancy
  • •Previous iliac vein intervention
  • •Previous superficial vein intervention
  • •Infection in previous 30 days
  • •Estimated glomerular filtration rate (eGFR) < 60 mls/kg/min
  • •Isolated short saphenous or perforator vein reflux only
  • •Leg ulcer of non-venous aetiology (as assessed by clinician)
  • •Unfit for endovascular intervention based on history and examination
  • •Any compression therapy within six-months
  • •Evidence of deep venous incompetence/thrombosis

研究组 & 干预措施

Control Group

Active Comparator

Endovenous ablation of Great Saphenous Vein

干预措施: Endovenous ablation of Great Saphenous Vein (Device)

Intervention Group

Experimental

Endovenous ablation + iliac US +/- iliac stenting

干预措施: Endovenous ablation + iliac US +/- iliac stenting (Device)

结局指标

主要结局

Ulcer Healing - Proportion of ulcers healed

时间窗: 3-months

Proportion of ulcers healed

Iliac Vein Patency on duplex ultrasound

时间窗: 6-months

Patency of the iliac vein on duplex

Reintervention

时间窗: 12-months

Freedom from re-intervention

次要结局

  • Recurrence - Ulcer recurrence(12-months)
  • Patient Quality of life using the Aberdeen Varicose Vein Questionnaire(12-months)
  • Ulcer healing - Time to ulcer healing(In days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Thomas Aherne

Principle Investigator Dr Thomas Aherne

National University of Ireland, Galway, Ireland

研究点 (2)

Loading locations...

相似试验

DEep VEin Lesion OPtimisation (DEVELOP) Trial | 临床试验